Retispec’s innovative AI technology transforming Alzheimer’s disease screening

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Retispec’s AI-driven retinal scan was featured in Global News. The feature showcased an initiative led by the Davos Alzheimer’s Collaborative to assess the feasibility of utilizing RetiSpec’s AI technology in community-based settings for Alzheimer’s disease screening.

Retispec is an OBIO® member, an alumnus of the BDSP™, CAAP®, H2BB™, HealthMINT™ and WiHI programs and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Rostrum Medical announces the publication of initial validation results of its novel VQm® System
Next

ImmunoBiochem enters a deal with ImmunoGen to develop next-generation antibody-drug conjugates